Share on StockTwits

Bioquell plc (LON:BQE) was upgraded by stock analysts at N+1 Singer to a “buy” rating in a report issued on Tuesday. The firm currently has a GBX 112 ($1.85) target price on the stock. N+1 Singer’s price objective points to a potential upside of 25.84% from the company’s current price.

Shares of Bioquell plc (LON:BQE) traded down 1.66% on Tuesday, hitting GBX 89.00. 46,591 shares of the company’s stock traded hands. Bioquell plc has a 52-week low of GBX 88.50 and a 52-week high of GBX 154.00. The stock’s 50-day moving average is GBX 94.8 and its 200-day moving average is GBX 115.4. The company’s market cap is £37.8 million.

Bioquell PLC is a holding company. It is engaged in the principal activities of designing, manufacturing and supplying of bio-decontamination and containment equipment, related products and services to the healthcare, life sciences and defense industries, and testing, regulatory and compliance services to a range of companies, including the aerospace, telecoms and defense industries.

Receive News & Ratings for Bioquell plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioquell plc and related companies with Analyst Ratings Network's FREE daily email newsletter.